Italia markets close in 6 hours 54 minutes

Codexis, Inc. (CDXS)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
2,1800+0,0350 (+1,63%)
Alla chiusura: 04:00PM EST
2,1600 -0,02 (-0,92%)
Dopo ore: 04:36PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente2,1450
Aperto2,1900
Denaro0,0000 x 1000
Lettera0,0000 x 3100
Min-Max giorno2,0750 - 2,2400
Intervallo di 52 settimane1,4500 - 6,9800
Volume488.354
Media Volume833.533
Capitalizzazione152,23M
Beta (5 anni mensile)1,87
Rapporto PE (ttm)N/D
EPS (ttm)-1,2100
Prossima data utili21 feb 2024 - 26 feb 2024
Rendimento e dividendo (futuro)N/D (N/D)
Data ex dividendoN/D
Stima target 1A5,83
  • GlobeNewswire

    Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award

    Stephen Dilly Headshot Stephen Dilly, MBBS, PhD, President & CEO of Codexis, Inc. REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced President and Chief Executive Officer Stephen Dilly, MBBS, PhD, has been named the winner of the prestigious 2023 Bloom Burton Award. Dr. Dilly was recognized for his leadership of Vancouver-headquartered Sierra Oncology where he led the company through Phase 3 clinical develo

  • GlobeNewswire

    Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award

    Stephen Dilly Headshot Stephen Dilly, MBBS, PhD, President & CEO of Codexis, Inc. REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Codexis, has been named a finalist for the prestigious 2023 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honors an individual who made the greatest contribu

  • GlobeNewswire

    Codexis to Participate in Cantor Global Healthcare Conference

    REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare Conference, being held September 26-28, 2023, in New York, New York. Management will participate in a fireside chat on Tuesday, September 26, 2023, at 9:20 am ET. A live webcast of the event will be available in the Investor Relations section of the Company’s website, http://ir.codexis.com. A replay will